Development of Cell Therapies for Renal Disease and Regenerative Medicine

The incidence of renal disease is gradually increasing worldwide, and this condition has become a major public health problem because it is a trigger for many other chronic diseases. Cell therapies using multipotent mesenchymal stromal cells, hematopoietic stem cells, macrophages, and other cell typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrico, Selene, Hotter, Georgina, Játiva, Soraya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783572/
https://www.ncbi.nlm.nih.gov/pubmed/36555585
http://dx.doi.org/10.3390/ijms232415943
_version_ 1784857609175564288
author Torrico, Selene
Hotter, Georgina
Játiva, Soraya
author_facet Torrico, Selene
Hotter, Georgina
Játiva, Soraya
author_sort Torrico, Selene
collection PubMed
description The incidence of renal disease is gradually increasing worldwide, and this condition has become a major public health problem because it is a trigger for many other chronic diseases. Cell therapies using multipotent mesenchymal stromal cells, hematopoietic stem cells, macrophages, and other cell types have been used to induce regeneration and provide a cure for acute and chronic kidney disease in experimental models. This review describes the advances in cell therapy protocols applied to acute and chronic kidney injuries and the attempts to apply these treatments in a clinical setting.
format Online
Article
Text
id pubmed-9783572
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97835722022-12-24 Development of Cell Therapies for Renal Disease and Regenerative Medicine Torrico, Selene Hotter, Georgina Játiva, Soraya Int J Mol Sci Review The incidence of renal disease is gradually increasing worldwide, and this condition has become a major public health problem because it is a trigger for many other chronic diseases. Cell therapies using multipotent mesenchymal stromal cells, hematopoietic stem cells, macrophages, and other cell types have been used to induce regeneration and provide a cure for acute and chronic kidney disease in experimental models. This review describes the advances in cell therapy protocols applied to acute and chronic kidney injuries and the attempts to apply these treatments in a clinical setting. MDPI 2022-12-15 /pmc/articles/PMC9783572/ /pubmed/36555585 http://dx.doi.org/10.3390/ijms232415943 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Torrico, Selene
Hotter, Georgina
Játiva, Soraya
Development of Cell Therapies for Renal Disease and Regenerative Medicine
title Development of Cell Therapies for Renal Disease and Regenerative Medicine
title_full Development of Cell Therapies for Renal Disease and Regenerative Medicine
title_fullStr Development of Cell Therapies for Renal Disease and Regenerative Medicine
title_full_unstemmed Development of Cell Therapies for Renal Disease and Regenerative Medicine
title_short Development of Cell Therapies for Renal Disease and Regenerative Medicine
title_sort development of cell therapies for renal disease and regenerative medicine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783572/
https://www.ncbi.nlm.nih.gov/pubmed/36555585
http://dx.doi.org/10.3390/ijms232415943
work_keys_str_mv AT torricoselene developmentofcelltherapiesforrenaldiseaseandregenerativemedicine
AT hottergeorgina developmentofcelltherapiesforrenaldiseaseandregenerativemedicine
AT jativasoraya developmentofcelltherapiesforrenaldiseaseandregenerativemedicine

Ejemplares similares